Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
Authors: Katarzyna We˛ gierek-Ciura*, Jagoda Mierzejewska, Agnieszka Szczygieł, Joanna Rossowska, Anna Wro´ blewska, Marta S´ witalska, Tomasz M. Goszczyn´ ski, Boz˙ena Szermer-Olearnik and Elz˙ bieta Pajtasz-Piasecka
Published in: Frontiers in Immunology
Publication type: article
Subject areas: Immunology and Microbiology; Medicine
SJR best quartile: Q1